Form EFFECT Oncotelic Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 21, 2025 |
| Accession Number: | 0001641172-25-004872 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Philadelphia Shooting Victim Civil Lawyer: The Victims' Recovery Law Center Pursues Financial Accountability for Gun Violence Victims Across Pennsylvania, New Jersey, and New York City
- CU SoCal CARES Brings Smiles to Local Youth Through Give Kids A Smile Day
- ShengShu Technology Unveils Vidu S1, Bringing Real-Time Interactive Generation to AI Video
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
